Posts made in December, 2017


Good news for patients suffering from Chronic Migraine or new daily persistent headache.  A retrospective review of 77 patients who underwent administration of intravenous, subanesthetic ketamine was conducted by investigators at Thomas Jefferson University. Their results were just published in Headache–the Journal of Head and Face Pain. The researchers found that the mean headache pain rating using a 0-10 pain scale was an average of...

Read More

Neuropathic pain is notoriously difficult to treat. Patients are often treated as regular chronic pain patients and many resort to opioids to manage extreme levels of pain. Neuropathic pain can originate from infection, metabolic diseases, chemotherapy, trauma and many other causes. It is often associated with alterations in pain response such as allodynia and shooting pain. Mechanisms for these neuropathic pain conditions are poorly...

Read More